Akebia Therapeutics, Inc. (AKBA) insider trading

By person

13 insiders · 18 transactions

4.7×

John P. Butler holds only 4.7 times base salary in stock. $4.13M of shares against $864.01K in salary for 2025.

Salary from the company's own proxy. The shares are what John P. Butler last reported holding, valued at $1.11, the price Common Stock was last bought or sold at on the open market here, on 29 Jun 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

John P. Butler

CEO and President

$86.59K (1)

$474.41K (4) scheduled

−$387.83K

3,718,564

1.34%

$4.13M

+68.1%

Nicholas Grund

Chief Commercial Officer

—

$117.91K (2) scheduled

−$117.91K

561,750

0.2027%

$623.54K

+85.2%

Erik Ostrowski

SVP, CFO, CBO & Treasurer

—

$110.76K (2) scheduled

−$110.76K

616,616

0.2225%

$684.44K

+76.2%

Carolyn M. Rucci

SVP, Chief Legal Officer

—

$96.98K (3) scheduled

−$96.98K

588,378

0.2123%

$653.10K

+25.7%

Steven Keith Burke

SVP, Chief Medical Officer

—

$94.04K (3) scheduled

−$94.04K

948,432

0.3423%

$1.05M

+40.5%

Richard C Malabre

SVP, Chief Accounting Officer

—

$68.84K (2) scheduled

−$68.84K

299,390

0.1080%

$332.32K

+31.1%

Adrian Adams

Director

—

236,200

0.0852%

$262.18K

+43.3%

Michael W Rogers

Director

—

197,429

0.0712%

$219.15K

+56.7%

Cynthia Smith

Director

—

196,633

0.0710%

$218.26K

+57.0%

Myles Wolf

Director

—

169,081

0.0610%

$187.68K

+73.1%

Ron Frieson

Director

—

165,200

0.0596%

$183.37K

+124.2%

Steven C Gilman

Director

—

152,830

0.0552%

$169.64K

+30.5%

Leanne M Zumwalt

Director

—

145,100

0.0524%

$161.06K

+96.9%

Akebia Therapeutics, Inc.

What the insiders did Net buying

By person